Health Care & Life Sciences » Pharmaceuticals | Jaguar Animal Health Inc.

Jaguar Animal Health Inc. | Mutual Funds

Mutual Funds that own Jaguar Animal Health Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Perpetual UK 2 Invt. Series - UK Strategic Income Fund
1,812,744
19.02%
1,372,556
0.25%
03/29/2018
Perpetual Income & Growth Investment Trust Plc
55,130
0.57%
55,130
0%
03/31/2018
AlphaNorth Growth Fund
33,334
0.35%
33,334
1.08%
12/31/2017
Fidelity Spartan Extended Market Index Fund
29,930
0.31%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
6,285
0.07%
0
0%
09/06/2018
2,550
0.03%
0
0.01%
09/05/2018

About Jaguar Animal Health

View Profile
Address
201 Mission Street
San Francisco California 94105
United States
Employees -
Website http://www.jaguar.health
Updated 07/08/2019
Jaguar Health, Inc. engages in the dvelopment of gastrointestinal products for both human prescription use and animals. Its products include Mytesi, Canalevia, Equilevia, and Neonorm. The Mytesi product IS use for relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.